ATE267398T1 - Verfahren zum nachweis einer prädisposition für venöse thromboembolische erkrankungen - Google Patents

Verfahren zum nachweis einer prädisposition für venöse thromboembolische erkrankungen

Info

Publication number
ATE267398T1
ATE267398T1 AT00912731T AT00912731T ATE267398T1 AT E267398 T1 ATE267398 T1 AT E267398T1 AT 00912731 T AT00912731 T AT 00912731T AT 00912731 T AT00912731 T AT 00912731T AT E267398 T1 ATE267398 T1 AT E267398T1
Authority
AT
Austria
Prior art keywords
detecting
predisposition
venous thromboembolic
thromboembolic diseases
subject
Prior art date
Application number
AT00912731T
Other languages
English (en)
Inventor
Joseph Emmerich
Jean-No Fiessinger
Martine Aiach
Original Assignee
Inst Nat Sante Rech Med
Assist Publ Hopitaux De Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Assist Publ Hopitaux De Paris filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE267398T1 publication Critical patent/ATE267398T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56927—Chlamydia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00912731T 1999-03-23 2000-03-22 Verfahren zum nachweis einer prädisposition für venöse thromboembolische erkrankungen ATE267398T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9903613A FR2791436B1 (fr) 1999-03-23 1999-03-23 Methode de determination d'une predisposition a une maladie tromboembolique veineuse et utilisation d'agents actifs sur les chlamydia pour la prevention et/ou le traitement de cette maladie
PCT/FR2000/000725 WO2000057186A1 (fr) 1999-03-23 2000-03-22 Methode de determination d'une predisposition a une maladie thromboembolique veineuse

Publications (1)

Publication Number Publication Date
ATE267398T1 true ATE267398T1 (de) 2004-06-15

Family

ID=9543540

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00912731T ATE267398T1 (de) 1999-03-23 2000-03-22 Verfahren zum nachweis einer prädisposition für venöse thromboembolische erkrankungen

Country Status (7)

Country Link
EP (1) EP1163523B1 (de)
JP (1) JP2002540403A (de)
AT (1) ATE267398T1 (de)
CA (1) CA2366555A1 (de)
DE (1) DE60010872T2 (de)
FR (1) FR2791436B1 (de)
WO (1) WO2000057186A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI883067A7 (fi) * 1988-06-27 1989-12-28 Labsystems Oy Foerfarande foer behandling av koronarkaerlsjukdom.
AU2249892A (en) * 1991-06-14 1993-01-12 Board Of Regents Of The University Of Washington, The Diagnosis and treatment of arterial chlamydial granuloma
US6291437B1 (en) * 1996-08-14 2001-09-18 The Wistar Institute Of Anatomy And Biology Methods and compositions for retarding the development of atherosclerotic lesions
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease

Also Published As

Publication number Publication date
WO2000057186A1 (fr) 2000-09-28
EP1163523A1 (de) 2001-12-19
JP2002540403A (ja) 2002-11-26
FR2791436B1 (fr) 2001-06-15
FR2791436A1 (fr) 2000-09-29
EP1163523B1 (de) 2004-05-19
CA2366555A1 (fr) 2000-09-28
DE60010872T2 (de) 2005-06-09
DE60010872D1 (de) 2004-06-24

Similar Documents

Publication Publication Date Title
FR2811970B1 (fr) Procede de determination des parametres de freinage, de traction et d'autres parametres de performance associes d'un ascenseur
WO2007079331A3 (en) Antibacterial oral rinse formulation for preventing coronary artery disease
EP1304323A4 (de) Wirkstoffe zur vorbeugung oder behandlung von atopischer dermatitis
EA200300027A1 (ru) Способ лечения сердечно-сосудистых заболеваний
GB9902555D0 (en) Medicament
BR0016652A (pt) Métodos para inibir angiopatia amilóide cerebral, para tratar um estado de doença caracterizado por angiopatia amilóide cerebral em um indivìduo, e para diagnosticar angiopatia amilóide cerebral em um indivìduo
ATE294031T1 (de) Reinigungsverfahren welches ultraschallwellen verwendet
PL366081A1 (en) Polysiloxane polymers, method for their production and the use thereof
DE69519747D1 (de) Enzymatisches verfahren zum nachweis coliformer bakterien oder e.coli
MA26782A1 (fr) Pyrazolobenzodiazepines en tant qu'inhibiteurs de cdk2.
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
ATE318189T1 (de) Reinigungsverfahren welches ultraschallwellen verwendet
WO2004007743A3 (en) Use of cpg nucleic acids in prion-disease
AU2085502A (en) Diagnosis and treatment of disease
PT1052905E (pt) Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol
UY25677A1 (es) Nuevos agentes bacterianos de isoxazolinona
WO2001058476A3 (en) Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
ATE311599T1 (de) Kombinierte zellensysteme zum nachweis von viren
AR037870A1 (es) Metodo para determinar la actividad biologica de defibrotida
FR2811895B1 (fr) Composition de traitement cosmetique comprenant au moins un betainate d'amidon specifique et au moins un tensioactif detergent, procede de traitement cosmetique des matieres keratiniques et utilisation de la composition
WO2001087239A3 (en) Methods of affecting laminin 5 processing
EP0992549A4 (de) Fäulnisverhinderndes mittel, verfahren zur fäulnisverhindernden behandlung und durch diese behandlung erhaltener gegenstand
DE69936774D1 (de) Strukturproteine des virus, welches die pankreas-krankheit bei fischen verursacht, und ihre verwendungen
DE60010872D1 (de) Verfahren zum nachweis einer prädisposition für venöse thromboembolische erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties